CN1231922A - Medicine for treatment of cancer - Google Patents
Medicine for treatment of cancer Download PDFInfo
- Publication number
- CN1231922A CN1231922A CN99112107A CN99112107A CN1231922A CN 1231922 A CN1231922 A CN 1231922A CN 99112107 A CN99112107 A CN 99112107A CN 99112107 A CN99112107 A CN 99112107A CN 1231922 A CN1231922 A CN 1231922A
- Authority
- CN
- China
- Prior art keywords
- medicine
- treatment
- cancer
- sulfur
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 45
- 201000011510 cancer Diseases 0.000 title claims description 25
- 229940079593 drug Drugs 0.000 title description 14
- 241000208340 Araliaceae Species 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 12
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 11
- 210000002826 placenta Anatomy 0.000 claims abstract description 11
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 11
- 239000011593 sulfur Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 8
- 239000002775 capsule Substances 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 20
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 11
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 11
- 241000717739 Boswellia sacra Species 0.000 claims description 10
- 241000283956 Manis Species 0.000 claims description 10
- 241001057584 Myrrha Species 0.000 claims description 10
- 241000405217 Viola <butterfly> Species 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 239000004863 Frankincense Substances 0.000 claims description 6
- 241000245240 Lonicera Species 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 3
- HJTAZXHBEBIQQX-UHFFFAOYSA-N 1,5-bis(chloromethyl)naphthalene Chemical compound C1=CC=C2C(CCl)=CC=CC2=C1CCl HJTAZXHBEBIQQX-UHFFFAOYSA-N 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- GOLCXWYRSKYTSP-UHFFFAOYSA-N arsenic trioxide Inorganic materials O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000006378 damage Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 201000009030 Carcinoma Diseases 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000012991 uterine carcinoma Diseases 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- 208000006678 Abdominal Neoplasms Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000004796 pathophysiological change Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000005909 tumor killing Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A medicine in the form of capsules or powder for curing cancers is prepared from 16 Chinese-medicinal materials such as sulfur, arsenic trioxide, ginseng, pilose antler, human placenta, etc through crushing, proportioning and sterilization. It features unique prescription and distinct curative effect.
Description
The present invention relates to a kind of medicine for the treatment of cancer.It specifically is each Chinese patent medicine of raw material system with the Chinese herbal medicine.
Tumor is a commonly encountered diseases, and benign tumor is seen than malignant tumor more, but malignant tumor (being cancer) is one of serious disease of harm humans health.
Motherland's medical science is thought the morbidity of tumor, is under the various factors influence, makes organism balance imbalance, the imbalance of internal organs meridian function, causes the pent-up of QI and blood expectorant food to build up and forms.Wherein QI and blood stasis of blood knot is main aspect, and they form vicious cycle each other again.Because the paathogenic factor of tumor is had nothing in common with each other, its pathophysiological change is respectively inclined to one side to some extent again, as the women
Abdominal mass is " blood " relatively, and pulmonary carcinoma, gastric cancer is " gas " relatively, and the neck goiter is " expectorant " relatively, and abdominal tumor is " food " etc. relatively.For tumor treatment, the theory of modern adopt " cancer pyretic toxicity opinion " more.Generally eliminate tumor with the cold and cool medicine of " heat-clearing and toxic substances removing ".Though its result is effective, cures the symptoms, not the disease, and does not cut the essence of tumor.Only play the respite symptom, dwindle the purpose of tumor, fundamentally do not dispel tumor, recover the normal function of body.The author thinks that cancer surely belongs to cloudy disease, and nothing " poison "." element asks YIN YANG classification of natural phenomena a big opinion piece of writing " said: " yang transforming qi, yin shaping up body "; " cold tending to injure the configuration, heat impairing vital QI.Impairment of QI resulting in pain, injury of configuration resulting in swelling.The person so bitterly then swell earlier, impairment of QI resulting in injury of the configuration is also; Swollen earlier pain person then, injury of configuration resulting in impairment of QI is also ".This shows that its morbidity of sun pain person is that pain is then swollen earlier, belongs to positive disease; Cancer then is to form the tumor stage in early days, and the patient also can not help bitterly, and in the later stage of having only carcinoma to form, there is pain patient side.It serves to show that cancer should belong to cloudy disease.Because have only cloudy disease just to meet " cold tending to injure the configuration " law of development of " injury of configuration resulting in impairment of QI " then.The contrast "The Book of Changes".Carcinoma should belong to blunt divinatory symbol, and leukemia should belong to the shake divinatory symbol.The two is all " excess of YIN leading to deficiency of YANG ", also it can be described.Therefore the Chinese traditional treatment cancer should adopt the method for " YANG invigorating presses down cloudy ", rather than the method for " heat-clearing and toxic substances removing ".
The objective of the invention is to adopt brand-new theory of Chinese medical science, a kind of prescription that presses down cloudy method treatment cancer with YANG invigorating is provided.This medicine can suppress effectively and eliminate tumor, alleviating pain, and enhancing human body immunity power is recovered the normal function of body; Overcome the drawback of curing the symptoms, not the disease that cold and cool Drug therapy cancer is produced.The clarification traditional Chinese medical science is to the understanding of cancer and blindly treatment.
Technical scheme of the present invention is based on theory of Chinese medical science, cold tending to injure the configuration, cold then the knot, the Therapeutic Method of " YANG invigorating presses down cloudy ", is adopted in the elaboration that knot then coagulates with reference to the modern pharmacological research achievement, from motherland's medicine treasure-house, filter out the medicine of big heat, supplementing the fire of vital gate to invigo rate YANG, be used for cold relieving, loose and condense.Eliminate tumor, and be equipped with and fill blood, the replenishing essence marrow, hot loose warm, the antiinflammatory blood stasis dispelling, detoxifcation antiseptical medicine is helped it, eliminating pathogenic factor for supporting vital QI reaches heat production tonifying YANG, hot eliminating stagnation, suppresses the cell cancerization, recovers the effect of normal function.
Medicine of the present invention is made by following component: (consumption is a weight portion)
Sulfur 50～200 Arsenicum sablimatum 10～80 Radix Ginsengs 30～80 Cornu Cervi Pantotrichums 30～80
Placenta Hominis 50～150 Fructus Piperiss 150～300 Olibanums 10～30 Myrrhas 10～30
Flos Lonicerae 30～60 Fructus Forsythiae 30～60 Flos Chrysanthemi Indicis 30～60 Herba Violaes 30～60
Thousand do not stay row 6～30 river Squama Manis 6～30 Borneolum Syntheticums 6～30 Colophonium 50～250
Formula optimization weight (part) ratio range of preparation medicine of the present invention is:
Sulfur 85～150 Arsenicum sablimatum 18～65 Radix Ginsengs 45～67 Cornu Cervi Pantotrichums 45～67
Placenta Hominis 75～110 Fructus Piperiss 180～250 Olibanums 15～25 Myrrhas 15～25
Flos Lonicerae 40～50 Fructus Forsythiae 40～50 Flos Chrysanthemi Indicis 40～50 Herba Violaes 40～50
Semen Vaccariae 10～23 river Squama Manis 10～23 Borneolum Syntheticums 10～22 Colophonium 80～200
The optimum weight of medicine of the present invention (part) proportioning is:
Sulfur 115 Arsenicum sablimatum 43 Radix Ginsengs 55 Cornu Cervi Pantotrichums 55 Placenta Hominiss 95 Fructus Piperiss 215
Olibanum 20 Myrrhas 20 Flos Loniceraes 45 Fructus Forsythiae 45 Flos Chrysanthemi Indicis 45 Herba Violaes 45
Semen Vaccariae 16 river Squama Manis 16 Borneolum Syntheticums 16 Colophonium 140
Above-mentioned each component is made medicine production method of the present invention: earlier all medicines are ground respectively to 120 order fine powders, by described mixed, said dosage form on any pharmaceuticss such as capsule, pill, tablet, powder is made in sterilization.
The present invention treats in the prescription of cancer, monarch drug: sulfur, grasp the essence of pure sun, compose the property of big heat, warm and cold expelling, have heat production, mend fire, tonifying YANG, but the effect of the moon.Arsenicum sablimatum, acrid in the mouth acid, hot in nature, poisonous has the function of hot eliminating stagnation, misfortune expectorant preventing the attack (or recurrence) of malaria, parasite killing, erosion evil meat.Two medicine compatibilities complement each other, and have given full play to this prescription and have produced big heat, benefit kidney-Yang, cold expelling knot, detumescence tumor, press down the effect of cloudy disease.Ministerial drug: Radix Ginseng, Cornu Cervi Pantotrichum, Placenta Hominis are all had an effect of strongly invigorating QI and blood, supplying vital essence and marrow, can assist healthy energy, promote the monarch drug efficacy of a drug to bring into play lastingly, and the body that QI and blood is declined greatly transforms to health.Fructus Piperis is joined usefulness in a large number more in addition, with the merit of its hot pure sun, and assistant hot with Arsenicum sablimatum, the tumor that deficiency and coldness is condensed has the merit of dissipation softening the hard mass.Adjuvant drug: but Olibanum, Myrrha, Semen Vaccariae blood circulation promoting are beneficial to drug absorption and effect performance, reducing swelling and alleviating pain simultaneously.Flos Lonicerae, Fructus Forsythiae, Flos Chrysanthemi Indici, Herba Violae ginseng usefulness in addition, with flat, cool property pin down heat too, it is anticorrosion also to detoxify simultaneously.Messenger drug: Borneolum Syntheticum, river Squama Manis, Colophonium are led all medicine infiltrations, make medicine absorb rapidly.(the Colophonium one product bone marrow that goes directly, can promote sclerotin new life at puckery and controlling nocturnal emission with astringent drugs.Clinic trial has the excellent repairing effect to osteocarcinoma, is do one's utmost in the Compendium of Materia Medica good medicine of the life prolonging recommended of Li Shizhen (1518-1593 A.D.)).
From above prescription, it has only with prescription just to meet the dialectical traditional Chinese medical science principle of controlling of executing with single completely different with Herba indigoferae Pseudotinctoriae oncotherapy on probation, and what just meet eliminating pathogenic factor for supporting vital QI executes method of treatment then.Just can reach treating both the principal and secondary aspects of a disease, consolidate the effect of radically reforming.
The present invention treats the medicine of cancer, and the zoopery of toxicological study chamber proves through Shandong Medical University: toxicity grade scale per os LD
50＞5000mg/kg belongs to low toxicity or does not have cytotoxic drug.Press down the tumor experiment, according to pressing down tumor therapeutic evaluation standard, suppression ratio surpasses national standard 15%, and twice experiment all has 10% tumor disappearance.
The experimental result for the treatment of cancer drug according to clinical use the present invention shows: this medicine all has better curative effect to various tumors and leukemia.The a few days sees that promptly leukaemic's hemogram takes a turn for the better after taking medicine, and tumor patient tumor body obviously dwindles.To advanced carcinoma is painful the persistency analgesic effect arranged.All have no adverse reaction and toxicity, side effect after various cancer patients take medicine, all can reach the effect of relief of symptoms life-saving.
From clinical observation, this medicine is not only effective in cure to cancer, and painful to heart strand, and cardiac extra systole has the effect of removing symptom immediately.The apoplexy that causes for cerebrovascular disease (comprising ischemic or hemorrhagic), if the cerebrovascular disease peripheral cell organize necrosis does not appear as yet and before, can both in a couple of days, alleviate.
The present invention treats the medicine of cancer, through 189 routine patient system's clinical observations, and selects medical history, the state of an illness, age, sex and the suitable patient of original therapy method to compare experiment for matched group, and total effective rate reaches 98.2%.Cure rate is 13%, improves 66% than existing Chinese medicine anticancer effect.And do not see any toxicity, side effect.In to all kinds of treatment for cancer effect observations, anticarcinogen of the present invention is the most obvious to the tumor killing effect of pulmonary carcinoma, hepatocarcinoma, uterus carcinoma, gastric cancer, effective percentage is all above 99.4%, cure rate: pulmonary carcinoma reaches 15%, uterus carcinoma reaches 11%, gastric cancer reaches 13%, hepatocarcinoma reaches 5%, and for the patient without chemotherapy and radiation, cure rate is higher.
The present invention is further illustrated below in conjunction with embodiment: (below be weight portion)
Embodiment 1:
215 parts in 95 portions of Fructus Piperiss of 55 parts of Placenta Hominiss of 55 parts of Cornu Cervi Pantotrichums of 43 parts of Radix Ginsengs of 115 parts of Arsenicum sablimatum of sulfur
45 parts of 45 portions of Herba Violaes of 45 parts of Flos Chrysanthemi Indicis of 45 parts of Fructus Forsythiae of 20 parts of Flos Loniceraes of 20 parts of Myrrhas of Olibanum
140 parts of 16 parts of Colophonium of 16 parts of Borneolum Syntheticums of 16 parts of river Squama Manis of Semen Vaccariae
Above-mentioned all medicines are ground respectively to 120 order fine powders, be mixed in proportion, sterilization, packing, make capsule.
Embodiment 2:
Sulfur 200 Arsenicum sablimatum 60 Radix Ginsengs 80 Cornu Cervi Pantotrichums 80 Placenta Hominiss 150 Fructus Piperiss 300
Olibanum 30 Myrrhas 30 Flos Loniceraes 60 Fructus Forsythiae 60 Flos Chrysanthemi Indicis 60 Herba Violaes 60
Semen Vaccariae 30 river Squama Manis 30 Borneolum Syntheticums 30 Colophonium 250
Above-mentioned all medicines are ground respectively to 120 order fine powders, be mixed in proportion, sterilize, make tablet.
Embodiment 3:
Sulfur 50 Arsenicum sablimatum 10 Radix Ginsengs 30 Cornu Cervi Pantotrichums 30 Placenta Hominiss 50 Fructus Piperiss 150
Olibanum 10 Myrrhas 10 Flos Loniceraes 30 Fructus Forsythiae 30 Flos Chrysanthemi Indicis 30 Herba Violaes 30
Semen Vaccariae 6 river Squama Manis 6 Borneolum Syntheticums 6 Colophonium 50
Above-mentioned all medicines are ground respectively to 120 order fine powders, be mixed in proportion, sterilize, make pill.
Claims (6)
1. medicine for the treatment of cancer, it is characterized in that: it is the medicament of being made by the following weight proportion raw material
Sulfur 50～200 Arsenicum sablimatum 10～80 Radix Ginsengs 30～80 Cornu Cervi Pantotrichums 30～80
Placenta Hominis 50～150 Fructus Piperiss 150～300 Olibanums 10～30 Myrrhas 10～30
Flos Lonicerae 30～60 Fructus Forsythiae 30～60 Flos Chrysanthemi Indicis 30～60 Herba Violaes 30～60
Semen Vaccariae 6～30 river Squama Manis 6～30 Borneolum Syntheticums 6～30 Colophonium 50～250
2. the medicine of treatment cancer according to claim 1, wherein the weight proportion of each raw material is:
Sulfur 85～150 Arsenicum sablimatum 18～65 Radix Ginsengs 45～67 Cornu Cervi Pantotrichums 45～67
Placenta Hominis 75～110 Fructus Piperiss 180～250 Olibanums 15～25 Myrrhas 15～25
Flos Lonicerae 40～50 Fructus Forsythiae 40～50 Flos Chrysanthemi Indicis 40～50 Herba Violaes 40～50
Semen Vaccariae 10～23 river Squama Manis 10～23 Borneolum Syntheticums 10～22 Colophonium 80～200
3. the medicine of treatment cancer according to claim 1, wherein the weight proportion of each raw material is:
Sulfur 115 Arsenicum sablimatum 43 Radix Ginsengs 55 Cornu Cervi Pantotrichums 55 Placenta Hominiss 95 Fructus Piperiss 215
Olibanum 20 Myrrhas 20 Flos Loniceraes 45 Fructus Forsythiae 45 Flos Chrysanthemi Indicis 45 Herba Violaes 45
Semen Vaccariae 16 river Squama Manis 16 Borneolum Syntheticums 16 Colophonium 140
4. according to the medicine of claim 1,2 or 3 described treatment cancers, it is characterized in that said medicament is a said dosage form on any pharmaceutics.
5. the medicine of treatment cancer according to claim 4 is characterized in that said medicament is capsule, pill, tablet or powder.
6. the medicine of treatment cancer according to claim 5 is characterized in that said medicament is capsule or powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99112107A CN1069541C (en) | 1999-03-15 | 1999-03-15 | Medicine for treatment of cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99112107A CN1069541C (en) | 1999-03-15 | 1999-03-15 | Medicine for treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1231922A true CN1231922A (en) | 1999-10-20 |
| CN1069541C CN1069541C (en) | 2001-08-15 |
Family
ID=5275443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99112107A Expired - Fee Related CN1069541C (en) | 1999-03-15 | 1999-03-15 | Medicine for treatment of cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1069541C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1120609C (en) * | 1999-09-01 | 2003-09-03 | 信息产业部武汉邮电科学研究院 | Adaption method for integrating Ethernet with quasi-synchronous digital system |
-
1999
- 1999-03-15 CN CN99112107A patent/CN1069541C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1120609C (en) * | 1999-09-01 | 2003-09-03 | 信息产业部武汉邮电科学研究院 | Adaption method for integrating Ethernet with quasi-synchronous digital system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1069541C (en) | 2001-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102258658B (en) | Plaster for invigorating blood circulation and relieving pain | |
| CN101590168B (en) | Traditional Chinese medicine combination for treating gout and preparation method thereof | |
| CN101028376A (en) | Chinese medicinal preparation for treating habitual abortion | |
| CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
| CN1682992A (en) | Medicine for nourishing qi and blood, warming yang, invigorating spleen and ten flavors, and its preparation method | |
| CN1184989C (en) | Weight-reducing Chinese medicine acted on acupoint | |
| CN1069541C (en) | Medicine for treatment of cancer | |
| CN1177600C (en) | Chinese medicine compound preparation for treating cervical spondylosis, and preparing process thereof | |
| CN1485071A (en) | Medicine for curing hydrocephalus, brain abscess and brain tumor and preparation process thereof | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN1158091C (en) | Chinese medicine composition for treating lung cancer | |
| CN1164287C (en) | Composite Chinese medicine powder for treating burns and scalds | |
| CN1537559A (en) | Traditional Chinese medicine for treating AIDS | |
| CN1824103A (en) | External use medicine for treating knocks and falls and bone joining | |
| CN1895593A (en) | Medicine for treating acne and its preparation | |
| CN101028421A (en) | Chinese medicine for treating chronic kidney failure | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1052908C (en) | "Chanhouning" and its preparation method | |
| CN1228313A (en) | Tonifying Yang anticancer powder for alimentary canal | |
| CN101049444A (en) | Preparation of Chinese traditional medicine for treating urethritis in non-gonococcus | |
| CN101062332A (en) | Traditional Chinese medicine for treating hematospermia type infertility | |
| CN100335112C (en) | Chinese medicine for treating kidney vacuity lumbar pain and preparation method of its capsule | |
| CN1167450C (en) | Medicine for treating hyperosteogeny and bone retromorphosis and its preparing process | |
| CN1394622A (en) | Medicine for curing burn and scald |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |